Plunkett Research Online: Emergent BioSolutions Inc

EMERGENT BIOSOLUTIONS INC (EBS:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibo.....



Emergent BioSolutions Inc
Ticker: EBS
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 240-631-3200
Fax:
Address: 400 Professional Drive
Suite 400
Gaithersburg, MD 20879 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines
Biodefense Vaccines
Oncology Therapeutics
Drug-Device Combination Products
Development Services
Contacts Description
Haywood MillerCEO
Richard LindahlCFO/Chief Accounting Officer/Executive VP/Treasurer
See More
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibo.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
ACAM2000
Anthrasil
NARCAN
AV7909
Trobigard
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: